Business Description
Eusol Biotech Co Ltd
ISIN : TW0006652001
Share Class Description:
ROCO:6652: Ordinary SharesDescription
Eusol Biotech Co Ltd is a Taiwan based company that invests in developing new drugs to fulfill unmet medical needs. Its pipeline products include ES135, a recombinant human acidic fibroblast growth factor (rhFGF1) with 135 amino acids; and SM-1, a 3-in-1 capsule containing 3 commercial drugs with the sedative effect.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 87.11 | |||||
| Equity-to-Asset | 0.98 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.1 | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 21.3 | |||||
| 3-Year EPS without NRI Growth Rate | 25.3 | |||||
| 3-Year FCF Growth Rate | 24.6 | |||||
| 3-Year Book Growth Rate | 12 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.91 | |||||
| 9-Day RSI | 41.69 | |||||
| 14-Day RSI | 41.03 | |||||
| 6-1 Month Momentum % | -4.36 | |||||
| 12-1 Month Momentum % | -26.31 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 52.68 | |||||
| Quick Ratio | 52.68 | |||||
| Cash Ratio | 49.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.1 | |||||
| Shareholder Yield % | -0.32 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -12.47 | |||||
| ROA % | -12.1 | |||||
| ROIC % | -111.79 | |||||
| ROC (Joel Greenblatt) % | -247.85 | |||||
| ROCE % | -11.76 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.85 | |||||
| Price-to-Tangible-Book | 2.85 | |||||
| EV-to-EBIT | -15.67 | |||||
| EV-to-EBITDA | -17.08 | |||||
| EV-to-FCF | -17.11 | |||||
| Price-to-Net-Current-Asset-Value | 2.9 | |||||
| Price-to-Net-Cash | 3.09 | |||||
| Earnings Yield (Greenblatt) % | -6.38 | |||||
| FCF Yield % | -3.77 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Eusol Biotech Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | |||
| EPS (TTM) (NT$) | -0.38 | ||
| Beta | -0.09 | ||
| Volatility % | 31.35 | ||
| 14-Day RSI | 41.03 | ||
| 14-Day ATR (NT$) | 0.415042 | ||
| 20-Day SMA (NT$) | 8.632 | ||
| 12-1 Month Momentum % | -26.31 | ||
| 52-Week Range (NT$) | 7.95 - 13.6 | ||
| Shares Outstanding (Mil) | 137 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Eusol Biotech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Eusol Biotech Co Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Eusol Biotech Co Ltd Frequently Asked Questions
What is Eusol Biotech Co Ltd(ROCO:6652)'s stock price today?
The current price of ROCO:6652 is NT$8.34. The 52 week high of ROCO:6652 is NT$13.60 and 52 week low is NT$7.95.
When is next earnings date of Eusol Biotech Co Ltd(ROCO:6652)?
The next earnings date of Eusol Biotech Co Ltd(ROCO:6652) is .
Does Eusol Biotech Co Ltd(ROCO:6652) pay dividends? If so, how much?
Eusol Biotech Co Ltd(ROCO:6652) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers